Literature DB >> 14671648

Evaluation of STR informativity for chimerism testing--comparative analysis of 27 STR systems in 203 matched related donor recipient pairs.

C Thiede1, M Bornhäuser, G Ehninger.   

Abstract

Chimerism analysis has become a routine method to document engraftment and also for detection of residual disease. PCR-based procedures using STR analysis, especially commercially available multiplex assays, are frequently used. However, these assays have been optimized for forensic purposes and do not necessarily fulfil all needs for chimerism analysis. To improve these analyses, data on the level of informativity of STR systems in the context of chimerism analysis would be helpful. We evaluated 27 STR markers for their informativity in 203 patients and their HLA-matched related donors. These STRs included 18 from different multiplex kits, whereas nine were selected from the literature or STR databases. The STR profiles were ranked from Type 1 (not informative) to Type 5 (best suited for chimerism analysis). According to this ranking, the informativity of the STR systems was found highly variable, ranging from 4.4 to 49.0% Type 5 constellations. Among the most informative STRs were Penta E, SE33, D2S1338 and D18S51. Informativity of an STR was correlated with the degree of heterozygosity (r=0.86; P=0.0001), but not with the total number of alleles present. These data indicate that selection of suitable STR markers is important to improve diagnostics based on STR analysis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14671648     DOI: 10.1038/sj.leu.2403212

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  13 in total

Review 1.  Hematologic aspects of myeloablative therapy and bone marrow transplantation.

Authors:  Roger S Riley; Michael Idowu; Alden Chesney; Shawn Zhao; John McCarty; Lawrence S Lamb; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

2.  Tri-allelic patterns at the D7S820 locus detected in two generations of a Chinese family.

Authors:  Erlie Jiang; Jie Pan; Mingzhe Han; Liang Chen; Qiaoling Ma; Jialin Wei; Yong Huang; Sizhou Feng; Qin Sun; Peili Xiao; Zhongzheng Zheng
Journal:  Int J Legal Med       Date:  2015-03-25       Impact factor: 2.686

3.  Indel analysis by droplet digital PCR: a sensitive method for DNA mixture detection and chimerism analysis.

Authors:  Ana Santurtún; José A Riancho; Jana Arozamena; Mónica López-Duarte; María T Zarrabeitia
Journal:  Int J Legal Med       Date:  2016-07-22       Impact factor: 2.686

4.  Bone marrow engraftment analysis after granulocyte transfusion.

Authors:  Sharon L Swierczynski; Michael J Hafez; Juliet Philips; Meghan A Higman; Karin D Berg; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

5.  Haplotype Counting for Sensitive Chimerism Testing: Potential for Early Leukemia Relapse Detection.

Authors:  Marija Debeljak; Evelina Mocci; Max C Morrison; Aparna Pallavajjalla; Katie Beierl; Marie Amiel; Michaël Noë; Laura D Wood; Ming-Tseh Lin; Christopher D Gocke; Alison P Klein; Ephraim J Fuchs; Richard J Jones; James R Eshleman
Journal:  J Mol Diagn       Date:  2017-05       Impact factor: 5.568

6.  Abundant cytomegalovirus (CMV) reactive clonotypes in the CD8(+) T cell receptor alpha repertoire following allogeneic transplantation.

Authors:  C S Link; A Eugster; F Heidenreich; E Rücker-Braun; M Schmiedgen; U Oelschlägel; D Kühn; S Dietz; Y Fuchs; A Dahl; A M J Domingues; C Klesse; M Schmitz; G Ehninger; M Bornhäuser; J Schetelig; E Bonifacio
Journal:  Clin Exp Immunol       Date:  2016-03-08       Impact factor: 4.330

7.  Hematopoietic chimerism monitoring based on STRs: quantitative platform performance on sequential samples.

Authors:  Don Kristt; Moshe Israeli; Ronit Narinski; Hagit Or; I Yaniv; Jerry Stein; Tirza Klein
Journal:  J Biomol Tech       Date:  2005-12

8.  Clinical Utility of the Detection of the Loss of the Mismatched HLA in Relapsed Hematological Patients After Haploidentical Stem Cell Transplantation With High-Dose Cyclophosphamide.

Authors:  Paula Muñiz; Mi Kwon; Diego Carbonell; María Chicano; Rebeca Bailén; Gillen Oarbeascoa; Julia Suárez-González; Cristina Andrés-Zayas; Javier Menárguez; Nieves Dorado; Ignacio Gómez-Centurión; Javier Anguita; José Luis Díez-Martín; Carolina Martínez-Laperche; Ismael Buño
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

9.  Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists.

Authors:  Zhenya Tang; L Jeffrey Medeiros; C Cameron Yin; Wei Wang; Xinyan Lu; Ken H Young; Joseph D Khoury; Guilin Tang
Journal:  Mol Cytogenet       Date:  2016-08-08       Impact factor: 2.009

10.  Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing.

Authors:  Vidya Balagopal; Andrew Hantel; Sabah Kadri; George Steinhardt; Chao Jie Zhen; Wenjun Kang; Pankhuri Wanjari; Lauren L Ritterhouse; Wendy Stock; Jeremy P Segal
Journal:  PLoS One       Date:  2019-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.